Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
miDiagnostics develops rapid, lab-quality point-of-care diagnostic tests using proprietary silicon lab-on-a-chip technology. Their platform enables detection of a broad array of biomarkers from minimal samples with high speed (~10 minutes) and accuracy. The company’s current focus includes syndromic infectious disease panels and an innovative sterility test to support batch release in the biopharmaceutical industry. Backed by major investors including Thermo Fisher Scientific, they are advancing toward full commercial deployment.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on miDiagnostics.